secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001683168-25-006274
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte raises $7M in private placement of Series C convertible preferred and warrants
--------------------------------------------------------------------------------

- Sale of 7,000 shares of Series C preferred (stated value $1,000) convertible into 7M common at $1.00 per share.
- Warrants to purchase 7M common shares at $1.00, exercisable immediately for 5 years.
- Preferred shares accrue a 7% quarterly dividend payable in cash; 15% upon trigger event.
- Company must seek stockholder approval by Oct 31, 2025 to issue >19.99% of outstanding common.
- Proceeds used for general corporate purposes and working capital; closing expected Aug 19, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825006274/0001683168-25-006274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825006274/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-006274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer